RAC 3.77% $1.53 race oncology ltd

MST valuation of RAC, page-163

  1. 2,879 Posts.
    lightbulb Created with Sketch. 2909
    Attached a summary of possible outcomes with risk in mind.

    Choose Your Own Adventure.pdf

    As an investor not too focused on the science (I will leave this to the scientists), but rather focused on the right entry and exit points for an investment. So far held from IPO and planning to hold until Buyout whilst being mindful of Risk v Reward along the way, albeit using the above to track progress. Fingers crossed of AAA+ outcome!

    Version 2 will consider probability of success, share price (each phase) and buyout values. Any feedback is welcomed (e.g. should we really consider licensing deal as a feasible option)?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.